Unlocking Microbiome Science For a Healthier Future

OpenBiome is radically increasing scientists’ understanding of the microbiome through our inclusive platform, unique research tools, and the most globally representative microbiome library of its kind.

Our Global Expansion

Building on our success as a pioneering biobank for fecal microbiota transplantation (FMT), OpenBiome is expanding our mission. We are working with scientists and community leaders from around the world to conserve microbiome diversity and catalyze research by sharing a globally representative microbiome library. This work is done through our new flagship program, the Global Microbiome Conservancy (GMbC) Program.

Learn more about the GMbC

Scientists traveling across a river in a boat

GMbC team commuting to a Jahai village within Royal Belum State Park in Malaysia. ©Global - Microbiome Conservancy / Photo by C. Corzett

Our Impact

Over the past 10 years, we've pushed scientific boundaries and set gold standards

A scientist in lab attire holding a stool sample bag

Patients have received urgently needed investigational fecal microbiota transplantation (FMT) treatments distributed by OpenBiome.

Learn About FMT

A group of scientists collecting and testing samples at a mobile site somewhere on the African continent

Participants from underrepresented communities have contributed stool samples to our microbiome library.

Learn About GMbC

OpenBiome Spotlights

As Microbiome Science Forges Ahead, Will Some Be Left Behind?

Harnessing the Microbiome to Prevent and Treat Malnutrition

Serving As a Last Line of Defense

for C. difficile Patients

To address global disparities, we need to include more diverse populations and increase representation in the leadership of science. Join us to improve health for all.

Severe acute malnutrition results in nearly 2 million preventable child deaths every year. OpenBiome's program in Malnutrition is bringing together a coalition of scientists to advance new therapies for this urgent public health threat.

To date, OpenBiome has provided more than 65,000 investigational fecal microbiota transplantation (FMT) treatments for patients with a debilitating intestinal infection known as C. difficile. Where standard antibiotic regimens fail, investigational FMT resolves approximately 80% of infections. Here is one FMT recipient's story.

Our Partners

OpenBiome is proud to have partnered with government and philanthropic organizations around the world to advance patient care and microbiome research.